Press Release

Global Antacids Market to grow with a CAGR of 3.43% through 2030

Increasing healthcare infrastructure and a supportive regulatory environment are expected to drive the Global Antacids Market growth in the forecast period, 2026-2030.

 

According to TechSci Research report, “Antacids Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2030”, Global Antacids Market was valued at USD 6.87 billion in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 3.43% through 2030. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market. Stressful lifestyles can drive the demand for antacids. Stress can have a significant impact on the gastrointestinal system and contribute to the development of acid-related disorders, which can lead to an increased need for antacids. Chronic stress can result in muscle tension, including in the abdominal area. Muscle tension can affect the proper functioning of the lower esophageal sphincter (LES), which normally prevents stomach acid from flowing back into the esophagus. This can lead to acid reflux and discomfort. Individuals experiencing high levels of stress may resort to unhealthy coping mechanisms, such as overeating, consuming comfort foods that are often high in fat, or engaging in excessive alcohol or caffeine consumption. These behaviors can trigger or worsen acid-related disorders. Stressful lifestyles can lead to irregular eating schedules or skipped meals. Irregular eating can affect stomach acid production and digestion, potentially contributing to indigestion. Stress can make the gastrointestinal system more sensitive to the effects of stomach acid, leading to an increased risk of experiencing symptoms like heartburn, acid indigestion, and upset stomach. Work-related stress, especially in demanding or high-pressure jobs, can be a common trigger for heartburn and indigestion. The demands of the job, long hours, and irregular breaks can contribute to these conditions.

 The market is expected to experience growth due to the development and approval of several new tablets designed to reduce gastric acid. For example, in August 2022, AstraZeneca received approval for a new tablet formulation that effectively reduced acid reflux in individuals with blood cancer. This development is likely to drive market growth, especially considering the increasing annual diagnoses of cancer patients, which further underscores the need for interventions in this patient population. In March 2023, Wonderbelly, a pioneering company in the clean medicine movement with a focus on digestive health, has announced the launch of its Wonderbelly Antacid chewable tablets in select Target stores and on Target.com. These tablets are known for their clean ingredients, appealing taste, and sustainable packaging. Wonderbelly Antacid, the flagship product of Wonderbelly, which is based in Austin, is an FDA-regulated over-the-counter remedy that provides immediate and efficient relief from heartburn, acid indigestion, and sour stomach. It contains the same active ingredient as leading brands, Calcium Carbonate, and is distinguished by being non-GMO, vegan, and free from talc, dyes, gluten, dairy, common allergens, synthetic sweeteners, artificial flavors, and parabens. In addition to addressing the less-discussed aspects of digestion, such as bloating, burping, and bowel movements, Wonderbelly is also contributing to the conversation about eating disorders and prevalent digestive health issues like GERD (chronic acid reflux), which can significantly impact the digestive system but are often overlooked.

Market saturation can be a challenge in the global antacids market. Market saturation occurs when a product category, in this case, antacids, has reached a point where most potential customers who would benefit from the product are already using it, leaving limited room for further expansion. With a limited pool of potential customers, competition among antacid manufacturers can become very fierce. Established brands may struggle to gain market share, and new entrants may find it difficult to establish a foothold. High competition often leads to price pressure, with manufacturers and retailers lowering prices to attract cost-conscious consumers. This can impact profit margins and the overall profitability of the antacids market. Market saturation can make it challenging for companies to introduce truly innovative products that stand out from the competition. Manufacturers may be compelled to focus on product differentiation or branding strategies. Established brands may have strong brand loyalty, making it difficult for newcomers to gain customer trust and market share. As the market saturates, attracting new consumers can require substantial efforts in consumer education. Manufacturers may need to invest in marketing campaigns to persuade consumers to switch brands or try new products.


Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Antacids Market.”


Global Antacids Market is segmented based on Type, End-Use, and by region. 

Based on type, the tablet category is showing the fastest growth in the Global Antacids Market, Tablets are simple and convenient to use. They offer a precise dosage, making it easier for consumers to control the amount they take, which is important when seeking relief from heartburn or indigestion. Tablets are highly portable, allowing users to carry them in their purse, pocket, or bag. This mobility is especially advantageous for individuals who may need antacids on the go. Tablets generally have a longer shelf life compared to liquid antacids. This means consumers can stock up on tablets without worrying about them expiring quickly. Tablets offer consistent and accurate dosing, which can be important for managing acid-related discomfort. Consumers can easily follow recommended dosage instructions. The tablets segment offers a wide variety of formulations, including chewable tablets, effervescent tablets, and traditional swallowable tablets. This variety allows consumers to choose a product that aligns with their preferences and needs. Chewable tablet formulations often come in various flavors, which can make them more appealing to consumers who prefer a specific taste. Unlike liquid antacids, tablets are mess-free. They don't spill, leak, or require special storage considerations. Some tablet formulations are designed to provide longer-lasting relief compared to liquid antacids. This can be an attractive feature for consumers seeking extended relief from heartburn and indigestion.

Based on Region, the Asia Pacific region is experiencing the fastest growth in the Global Antacids Market. This growth can be attributed to several factors, including the rising prevalence of acid-related digestive disorders, such as gastroesophageal reflux disease (GERD) and indigestion, in countries like China, India, and Japan. The region's increasing urbanization, changing dietary habits, and growing awareness about digestive health are also contributing to the demand for antacid products. Additionally, the expanding middle class and higher disposable incomes in Asia Pacific are driving the consumption of over-the-counter healthcare products, including antacids. The increasing availability of a wide range of antacid formulations and brands, along with growing healthcare infrastructure, further supports the market's rapid expansion in the region.

 

Some of the major companies operating in the Global Antacids Market include:

  • GlaxoSmithKline plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Dr. Reddy’s Laboratories Ltd.
  • Sanofi SA
  • Reckitt Benckiser Group plc
  • Sun Pharmaceuticals Ltd.
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Procter & Gamble Co.

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“Certain areas, particularly in North America, are projected to exert significant demand for Antacids. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Antacids Market in the forecast period," said Mr. Karan Chechi, Research Director at TechSci Research, a research-based Global management consulting firm.

"Antacids Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Tablet, Liquid, others), By End-use (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, and Competition, 2020-2030F", has evaluated the future growth potential of Global Antacids Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Antacids Market.


 

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: sales@techsciresearch.com               

Website: www.techsciresearch.com

Relevant Reports

Antacids Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Tablet, Liquid, others), By End-use (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F

Healthcare | Mar, 2025

Increasing Prevalence of Gastrointestinal Disorders is expected to drive the demand of Global Antacids Market in the forecast period 2026-2030.

Relevant News